Counterfeit Alert Network
In February 2004, FDA created the Counterfeit Alert Network, a coalition of
health professional and consumer groups. The Network has three goals:
- to disseminate alert messages to a wide audience about specific counterfeit
drug incidents in the U.S. and measures to take to minimize exposure (recall
information, for example);
- to develop educational information about the roles and responsibilities that
consumers, pharmacists, other health professionals, and wholesalers should
play to identify counterfeit drugs, report suspect counterfeit drugs, and
prevent them from entering the U.S. drug distribution system; and
- to develop a network of national organizations, consumer groups, and industry
representatives to help distribute the information.
These groups are current Counterfeit Alert Network members:
American Academy of Family Physicians
American Academy of Nurse Practitioners
American Academy of Physician Assistants
American College of Clinical Pharmacy
American College of Physicians
Academy of Managed Care Pharmacy
American Medical Association
American Pharmacists Association
American Society for Aesthetic Plastic Surgery
American Society of Health-System Pharmacists
Healthcare Distribution Management Association
National Association of Chain Drug Stores
National Association of Pediatric Nurse Practitioners
National Community Pharmacists Association
National Consumers League
Partnership for Safe Medicines
Physicians Coalition for Injectable Safety
|
|
In the event of a confirmed counterfeit case in the United States, FDA will
send an alert to these partners. The agency also will send partners a notice
if a counterfeit incident is confirmed elsewhere in the world that could
affect U.S. patients.
If your organization is interested in becoming a partner in the Counterfeit
Alert Network, contact Ilisa Bernstein at ilisa.bernstein@fda.hhs.gov.
